363 Vactosertib and durvalumab as second or later line treatment for PD-L1 positive non-small cell lung cancer: interim result by Byoung Chul Cho, Jin Kyung Lee, Jiyeon Ryu, Bitna Oh, Sunjin Hwang, Ki Baik Hahm, Seong-Jin Kim, Ki Hyeong Lee, Ji-Youn Han, Byoung Yong Shim, Hye Ryun Kim, Kyoung-Ho Pyo, Jae-Hwan Kim, Chung-Feng Xin